Showing 8361-8370 of 10736 results for "".
Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.Currents: Psoriasis: Optimizing Patient Care
https://practicaldermatology.com/topics/psoriasis/currents-psoriasis-optimizing-patient-care/23426/An Overview of Topical Acne Therapy
https://practicaldermatology.com/issues/supplements/an-overview-of-topical-acne-therapy/21619/It's important to recall the rationale for topical therapy, its occasional limitations, and its potential to benefit a majority of acne patients.Top Dermatology Marketing Trends for 2023
https://practicaldermatology.com/topics/practice-management/top-dermatology-marketing-trends-for-2023/23862/Are you up to date on trends in digital marketing?Patient-Centered Wound Healing
https://practicaldermatology.com/topics/feature/patient-centered-wound-healing/26645/Patient-Centered Wound HealingConfronting Biases to Improve Patient Care
https://practicaldermatology.com/topics/practice-management/confronting-biases-to-improve-patient-care/23501/Cognitive biases can lead to inaccurate diagnoses and a negative impact on patient care. But it’s possible to overcome the obstacles.Psoriasis, Biologics, and Cardiovascular Disease: The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/psoriasis-biologics-and-cardiovascular-disease-the-heart-of-the-matter/23215/A relationship between increased cardiovascular events in patients with psoriasis has implications for management of this chronic disease.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-43/23860/Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Managing Diaper Dermatitis
https://practicaldermatology.com/topics/pediatric/managing-diaper-dermatitis/20357/First-line treatment tips and a review of when to assess for an alternate diagnosis.